🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢 Hot off the press! CAFs are major regulators of the immune tumor microenvironment. In our new review we dissect a fascinating aspect of this regulation: CAF-induced physical constraints controlling T cell state and localization in solid tumours nature.com/articles/s4156…

The special issue of Cancer Research is now online for #AACRPan24. Here are some of the “cancer research landmarks” articles on #PancreaticCancer: (1) Cancer research landmarks on cancer associated fibroblasts (CAFs), by Giulia Biffi & colleagues aacrjournals.org/cancerres/arti… (2) Cancer

Great to be part of this special issue. Thank you very much Cancer Research for the opportunity to write about our favorite cell type 💜. A fantastic job from Gianluca Mucciolo and Wenlong Li ⭐️⭐️.

Classifying cancer-associated fibroblasts—The good, the bad, and the target dlvr.it/TDJ8xm

REVIEW Nature Immunology Belinda Parker The complexity of immune evasion mechanisms throughout the metastatic cascade nature.com/articles/s4159…

Planning to attend Plenary Session 3: Stromal Aspects of the Microenvironment & TME at #AACRpan24? Don’t miss this Landmark commentary by speaker Giulia Biffi—CAFs: From Spectators to Protagonists in #PancreaticCancer Progression. bit.ly/3Ty7w6R Gianluca Mucciolo

REVIEW Journal of Clinical Investigation Bhardwaj Lab Dr. Nina Bhardwaj Mesude Bicak Cansu Cimen Bozkus Checkpoint therapy in cancer treatment: progress, challenges, and future directions jci.org/articles/view/…

Online Now: Universal and tissue-specific fibroblasts in chronic inflammation and cancer dlvr.it/TDk9Jz

Excited to start a new position as a PhD student in the Giulia Biffi lab CRUK Cambridge Institute. Looking forward to characterising #metastases of #PancreaticCancer ✨

🚨We are 👀 for our next #Bioinformagician🚨 Do you have (preferably lots of) hands-on experience with single-cell/single-nuclei RNA-sequencing? Want to analyze our lab’s pancreatic cancer (and more) datasets? Join us ⁦CRUK Cambridge Institute⁩! Please RT 👇🏼 jobs.cam.ac.uk/job/48614/

After a successful review, Cancer Research UK has committed an unprecedented £173 million to our Institute. With this funding we will: 🔬Embrace new technologies 🩺Involve clinicians in all of our research 🏥Deliver real change for patients cruk.cam.ac.uk/news/institute… Cambridge University Hospitals NHS Cambridge University

👋Meet our panel of experts - Dr Giulia Biffi Giulia Biffi, a group leader CRUK Cambridge Institute, and member of Team #CANCAN Cancer Grand Challenges in our next #WorldPancreaticCancerDay💜webinar on #Cachexia! Book you ticket & submit your question TODAY👉shorturl.at/bj4R9

1st student to graduate from the lab! Congrats Joaquín Araos Henríquez !!! And thanks much Ainhoa and Doug for making time for this!

Today on #WorldPancreaticCancerDay, it's time to change the story. We need more breakthroughs, more support, more noise, more action. Will you stand together with us, and people like Tony who lost his wife Ruth, to bring more than hope? Sign today: bit.ly/4g0OYoN

🚨2024 is coming to a close but #research on #fibroblast_functions in #cancer is far from done ✅. If you want to know more, read our latest #review now in press Trends in Cancer. Fantastic job by Priscilla Cheng and Marta Zaccaria 🌟👏🏻. And happy 2025 🫶 sciencedirect.com/science/articl…

A really comprehensive fibroblast review in primary and metastatic cancers! In Trends in Cancer from Giulia Biffi Marta Zaccaria Priscilla Cheng Wonderful job! Illustrations below highlighting (A) Cues that contribute to fibroblast heterogeneity in cancer (B) Fibroblast Cancer cell

Our review discussing the functional crosstalk between #fibroblast subtypes and the #TME in primary and metastatic #cancers is out now in Trends in Cancer . Thank you Marta Zaccaria Giulia Biffi and the Biffi lab! doi.org/10.1016/j.trec…

A review to get you talking! 💬 Priscilla Cheng, Marta Zaccaria, and Dr. Giulia Biffi discuss recently identified functional interactions of #CAF subtypes with immune cells, and other stromal cells in primary tumors and metastases. CRUK Cambridge Institute 📚 bit.ly/4gAPbz8

🥳Happy to see Eloise Lloyd et al finally published! A beautiful study looking at how distinct #genetics of malignant cells shape #PDACprogression, #TMEcomposition and #TherapyResponse. 👇 aacrjournals.org/cancerres/arti… Also, for future posts see you on 🦋 @giuliabiffi.bsky.social

New Cancer Research paper from Giulia Biffi vincorbo and colleagues: SMAD4 and KRAS Status Shape Cancer Cell-Stromal Crosstalk and Therapeutic Response in #PancreaticCancer This study compares the effect of two distinct KRAS alleles (G12D and G12V) as well as the status of SMAD4